logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Acute poisoning with antihypertensive and antiarrhythmic medicines - clinicoepidemiological study

[Internal diseases]
Rayna Stoyanova; Julia Radenkova – Saeva;

The characteristics of acute poisoning with antihypertensive and antiarrhythmic medicines were investigated in the retrospective epidemiological study. All cases of antihypertensive and antiarrhythmic medicines (AAM) poisoning were analyzed for 3 years period. Demographic data, previous illness were obtained retrospectively. The cases of poisonings were evaluated with respect to clinical course, therapy and outcome. 896 patients with acute exogenous intoxications were treated. 136 cases (15.2 %) of them were poisoning with AAM – beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, etc. 95 (69.9 %) were female and 41 (30.1 %) male, between the ages of 18 and 98. 61 individuals (44.9 %) were poisoned by only one drug. In 75 (55.1 %) remaining cases, intoxications were mixed, including other different medications or psychoactive substances. 112 cases (86.8 %) were intentional – a result of a suicide attempt. The severity of poisonings varied from moderate to extremely severe. In 17 patients poisoning occurs with the signs of exotoxic shock, 3 of them – with fatal outcome. In the examined group three patients died of cardiogenic shock and secondary acute respiratory failure resistant to therapy. In conclusion, patients with acute poisoning from AAM were a large proportion of all patients, received acute poisoning and represent a serious challenge for the physician – toxicologist.

Download

References:
1. Bulgarian Hypertension League. ESH/ESC Guidelines for the management of arterial hypertension. Recommendations for behavior in arterial hypertension in clinical practice, 2013.
2. Dasgupta K., Quinn R., Zarnke K. [et al.] The 2014 Canadian Hypertension Education Program Recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can. J. Cardiol. 2014;30:485-501. doi: 10.1016/j.cjca.2014.02.002
3. Franklin S., Pio J., Wong N. [et al.] Predictors of newonset diastolic and systolic hypertension: the Framingham Heart Study. Circulation. 2005;111:1121-1127.
4. Glussepe Mancia G., Frang R., Narkiewicz K. [et al.] 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Forse for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the Europen Sociely of Cardiology (ESC) J. Hypertens. 2013;31:1281-1357. doi: 10.1097/01.hjh.0000431740.32696.cc
5. Grassi G., Cifkova R., Laurent S. [et al.] Blood pressure and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur. Heart J. 2011;32:218-25. doi: 10.1093/eurheartj/ehq394
6. James P., Oparil S., Carter B. [et al.] 2014 Evidencebased guidelines for the management of high blood pressure in adults. Report from the panel members appointed to the Eight Joint National Committee (JNC 8). JAMA. doi: 10.1001/jama.2013.284427
7. Law M. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: a meta-analysis of the 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. doi: 10.1136/bmj.b1665
8. Mancia G., Fagard R., Narkiewicz K. [et al.] 2013 ESH/ESC Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013;34:2159-2219. doi: 10.3109/08037051.2014.868629
9. Rosendorff C., Black H., Cannon C. [et al.] Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115:2761-2788.
10. Vasan R., Beiser S. A., Seshadri S. [et al.] Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287:1003-1010.

Keywords: acute poisoning, antihypertensive, antiarrhythmics medicines


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy